Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082018974> ?p ?o ?g. }
- W2082018974 endingPage "491" @default.
- W2082018974 startingPage "483" @default.
- W2082018974 abstract "Central mechanisms related to referred muscle pain and temporal summation of muscular nociceptive activity are facilitated in fibromyalgia syndrome (FMS) patients. The present study assessed the effects of an NMDA-antagonist (ketamine) on these central mechanisms. FMS patients received either i.v. placebo or ketamine (0.3 mg/kg, Ketalar®) given over 30 min on two separate occasions. Habitual pain intensity was assessed on a visual analogue scale (VAS). Initially, 29 FMS patients received ketamine or isotonic saline to determine which patients were ketamine responders (>50% decrease in pain intensity at rest by active drug on two consecutive VAS assessments). Fifteen out of 17 ketamine-responders were included in the second part of the study. Before and after ketamine or placebo, experimental local and referred pain was induced by intramuscular (i.m.) infusion of hypertonic saline (0.7 ml, 5%) into the tibialis anterior (TA) muscle. The saline-induced pain intensity was assessed on an electronic VAS, and the distribution of pain drawn by the subject. In addition, the pain threshold (PT) to i.m. electrical stimulation was determined for single stimulus and five repeated (2 Hz, temporal summation) stimuli. The pressure PT of the TA muscle was determined, and the pressure PT and pressure pain tolerance threshold were determined at three bilaterally located tenderpoints (knee, epicondyle, and mid upper trapezius). VAS scores of pain at rest were progressively reduced during ketamine infusion compared with placebo infusion. Pain intensity (area under the VAS curve) to the post-drug infusion of hypertonic saline was reduced by ketamine (−18.4±0.3% of pre-drug VAS area) compared with placebo (29.9±18.8%, P<0.02). Local and referred pain areas were reduced by ketamine (−12.0±14.6% of pre-drug pain areas) compared with placebo (126.3±83.2%, P<0.03). Ketamine had no significant effect on the PT to single i.m. electrical stimulation. However, the span between the PT to single and repeated i.m. stimuli was significantly decreased by the ketamine (−42.3±15.0% of pre-drug PT) compared with placebo (50.5±49.2%, P<0.03) indicating a predominant effect on temporal summation. Mean pressure pain tolerance from the three paired tenderpoints was increased by ketamine (16.6±6.2% of pre-drug thresholds) compared with placebo (−2.3±4.9%, P<0.009). The pressure PT at the TA muscle was increased after ketamine (42.4±9.2% of pre-drug PT) compared with placebo (7.0±6.6%, P<0.011). The present study showed that mechanisms involved in referred pain, temporal summation, muscular hyperalgesia, and muscle pain at rest were attenuated by the NMDA-antagonist in FMS patients. It suggested a link between central hyperexcitability and the mechanisms for facilitated referred pain and temporal summation in a sub-group of the fibromyalgia syndrome patients. Whether this is specific for FMS patients or a general phenomena in painful musculoskeletal disorders is not known." @default.
- W2082018974 created "2016-06-24" @default.
- W2082018974 creator A5001045429 @default.
- W2082018974 creator A5021090793 @default.
- W2082018974 creator A5044926546 @default.
- W2082018974 creator A5047811012 @default.
- W2082018974 creator A5048017178 @default.
- W2082018974 creator A5066047563 @default.
- W2082018974 creator A5073284225 @default.
- W2082018974 creator A5085168676 @default.
- W2082018974 date "2000-04-01" @default.
- W2082018974 modified "2023-10-17" @default.
- W2082018974 title "Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients" @default.
- W2082018974 cites W1500514965 @default.
- W2082018974 cites W1966192764 @default.
- W2082018974 cites W1968977406 @default.
- W2082018974 cites W1971194930 @default.
- W2082018974 cites W1971814254 @default.
- W2082018974 cites W1973839466 @default.
- W2082018974 cites W1975910531 @default.
- W2082018974 cites W1982173832 @default.
- W2082018974 cites W1985026857 @default.
- W2082018974 cites W1986237784 @default.
- W2082018974 cites W1987192367 @default.
- W2082018974 cites W1988059170 @default.
- W2082018974 cites W1989196480 @default.
- W2082018974 cites W1990352509 @default.
- W2082018974 cites W1990934806 @default.
- W2082018974 cites W1993697980 @default.
- W2082018974 cites W1995857215 @default.
- W2082018974 cites W2000808619 @default.
- W2082018974 cites W2003884564 @default.
- W2082018974 cites W2006618745 @default.
- W2082018974 cites W2013519018 @default.
- W2082018974 cites W2015303667 @default.
- W2082018974 cites W2020462265 @default.
- W2082018974 cites W2024437354 @default.
- W2082018974 cites W2030063836 @default.
- W2082018974 cites W2032836087 @default.
- W2082018974 cites W2034807464 @default.
- W2082018974 cites W2037284544 @default.
- W2082018974 cites W2038402091 @default.
- W2082018974 cites W2039945313 @default.
- W2082018974 cites W2042528713 @default.
- W2082018974 cites W2051318074 @default.
- W2082018974 cites W2054256232 @default.
- W2082018974 cites W2056060709 @default.
- W2082018974 cites W2058328677 @default.
- W2082018974 cites W2059441972 @default.
- W2082018974 cites W2062057327 @default.
- W2082018974 cites W2066869040 @default.
- W2082018974 cites W2067354763 @default.
- W2082018974 cites W2071567551 @default.
- W2082018974 cites W2073770824 @default.
- W2082018974 cites W2082705609 @default.
- W2082018974 cites W2089787597 @default.
- W2082018974 cites W2106520657 @default.
- W2082018974 cites W2112153811 @default.
- W2082018974 cites W2136571643 @default.
- W2082018974 cites W2146456944 @default.
- W2082018974 cites W2253364553 @default.
- W2082018974 cites W4232614478 @default.
- W2082018974 cites W4237144224 @default.
- W2082018974 doi "https://doi.org/10.1016/s0304-3959(99)00308-5" @default.
- W2082018974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10781923" @default.
- W2082018974 hasPublicationYear "2000" @default.
- W2082018974 type Work @default.
- W2082018974 sameAs 2082018974 @default.
- W2082018974 citedByCount "369" @default.
- W2082018974 countsByYear W20820189742012 @default.
- W2082018974 countsByYear W20820189742013 @default.
- W2082018974 countsByYear W20820189742014 @default.
- W2082018974 countsByYear W20820189742015 @default.
- W2082018974 countsByYear W20820189742016 @default.
- W2082018974 countsByYear W20820189742017 @default.
- W2082018974 countsByYear W20820189742018 @default.
- W2082018974 countsByYear W20820189742019 @default.
- W2082018974 countsByYear W20820189742020 @default.
- W2082018974 countsByYear W20820189742021 @default.
- W2082018974 countsByYear W20820189742022 @default.
- W2082018974 countsByYear W20820189742023 @default.
- W2082018974 crossrefType "journal-article" @default.
- W2082018974 hasAuthorship W2082018974A5001045429 @default.
- W2082018974 hasAuthorship W2082018974A5021090793 @default.
- W2082018974 hasAuthorship W2082018974A5044926546 @default.
- W2082018974 hasAuthorship W2082018974A5047811012 @default.
- W2082018974 hasAuthorship W2082018974A5048017178 @default.
- W2082018974 hasAuthorship W2082018974A5066047563 @default.
- W2082018974 hasAuthorship W2082018974A5073284225 @default.
- W2082018974 hasAuthorship W2082018974A5085168676 @default.
- W2082018974 hasConcept C126322002 @default.
- W2082018974 hasConcept C14184104 @default.
- W2082018974 hasConcept C142724271 @default.
- W2082018974 hasConcept C15490471 @default.
- W2082018974 hasConcept C170493617 @default.
- W2082018974 hasConcept C1862650 @default.
- W2082018974 hasConcept C204787440 @default.
- W2082018974 hasConcept C24998067 @default.